Resolve Biosciences

Series B

Munich, GermanyOct 2022

Resolve Biosciences raised €72M in a Series B round in Oct 2022. The company is based in Munich, Germany. Investors in the round: Alafi Capital, EDBI, NRW.BANK and 2 others. Data as of Nov 2026.

← Resolve Biosciences

Amount raised

€72M

€72,073,901

Native amount

71,000,000 USD

Stage

Series B

series b

Investors

Provenance & confidence

High confidence

Amount

71,000,000 USD

ECB-at-date → €72M · rate 0.9851 on 2022-10-24

High confidence

Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

5 named

Alafi Capital EDBI NRW.BANK Patient Square Capital PS Capital

Date

Oct 2022

Round type

series b

Amount (EUR)

€72M

Other rounds

same company

This is the company's only recorded round.

Resolve Biosciences

Provenance & confidence

Investors in this round

Other rounds

Related news